In the present study, we examined XAF1 promoter methylation in paired tissue and serum samples from a large panel of patients with gastric cancer, and evaluated circulating methylated XAF1 as a potential biomarker for gastric cancer. The gene discussed is XAF1; the disease is gastric cancer.